← Back to Search

Non-Invasive Respiratory Measurement for Upper Airway Resistance Syndrome

N/A
Waitlist Available
Research Sponsored by Walter Reed Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing a new, non-invasive way to measure respiratory effort in people with suspected upper airway resistance syndrome (UARS), compared to the current gold standard. If successful, this could provide a less invasive and more affordable option for diagnosis of UARS.

Who is the study for?
This trial is for adults over 18 suspected of having sleep-related breathing issues and referred for a sleep study. It's not suitable for pregnant individuals, those under 18, people with nasal defects that prevent esophageal manometer use, or patients on blood thinners.Check my eligibility
What is being tested?
The study aims to compare two methods of measuring respiratory effort: the new non-invasive forehead venous pressure/respiratory movement (FVP/RM) technique versus the traditional esophageal manometry method.See study design
What are the potential side effects?
Since this trial involves measurement techniques rather than medications, typical drug side effects are not expected. However, discomfort from wearing the devices may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of respiratory effort data generated by esophageal manometer with that generated by ARES device

Find a Location

Who is running the clinical trial?

Walter Reed Army Medical CenterLead Sponsor
69 Previous Clinical Trials
20,919 Total Patients Enrolled
Advanced Brain Monitoring, Inc.Industry Sponsor
3 Previous Clinical Trials
160 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00528749 — N/A
Upper Airway Resistance Syndrome Research Study Groups:
Upper Airway Resistance Syndrome Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00528749 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00528749 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being accepted for this investigation?

"Data posted to clinicaltrials.gov reveals that this specific trial, which was initially published on February 1st 2007, is not presently looking for participants. However, 1389 other studies are currently recruiting patients across the USA right now."

Answered by AI
~1 spots leftby Apr 2025